162 related articles for article (PubMed ID: 9805851)
1. A probable explanation for mild extra-articular manifestations in Indian patients of rheumatoid arthritis: a preliminary study.
Agrawal V; Usha ; Goel SC; Gupta RM
Indian J Pathol Microbiol; 1998 Jul; 41(3):297-301. PubMed ID: 9805851
[TBL] [Abstract][Full Text] [Related]
2. Does IgA-alpha1 antitrypsin complex correlate with IgM, IgG and IgA rheumatoid factor in early rheumatoid arthritis?
Lacki JK; Hrycaj P; Klama K; Mackiewicz U; Mackiewicz SH; Muller W
Mater Med Pol; 1994; 26(3):97-100. PubMed ID: 7603085
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis.
Newkirk MM; Goldbach-Mansky R; Senior BW; Klippel J; Schumacher HR; El-Gabalawy HS
Rheumatology (Oxford); 2005 Nov; 44(11):1433-41. PubMed ID: 16091399
[TBL] [Abstract][Full Text] [Related]
4. Role of IgM & IgA rheumatoid factors in complement activation in patients with juvenile rheumatoid arthritis.
Bhardwaj A; Aggarwal A; Agarwal V; Misra R
Indian J Med Res; 2000 Mar; 111():103-9. PubMed ID: 10937386
[TBL] [Abstract][Full Text] [Related]
5. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders.
Anzilotti C; Riente L; Pratesi F; Chimenti D; Delle Sedie A; Bombardieri S; Migliorini P
Rheumatology (Oxford); 2007 Oct; 46(10):1579-82. PubMed ID: 17717033
[TBL] [Abstract][Full Text] [Related]
6. Serum IgG and IgM rheumatoid factors and complement activation in extraarticular rheumatoid disease.
Jakle C; Feigal DW; Robbins DL; Shapiro R; Wiesner K
J Rheumatol; 1985 Apr; 12(2):227-32. PubMed ID: 3875718
[TBL] [Abstract][Full Text] [Related]
7. [The effect of Na-aurothiomalate on circulating immune complex dynamics in patients with rheumatoid arthritis].
Vlak T; Jajić I
Reumatizam; 1992; 39(2):1-5. PubMed ID: 1366145
[TBL] [Abstract][Full Text] [Related]
8. Complement activation by 19S IgM rheumatoid factor: relationship to disease activity in rheumatoid arthritis.
Robbins DL; Fiegal DW; Leek JC; Shapiro R; Wiesner K
J Rheumatol; 1986 Feb; 13(1):33-8. PubMed ID: 3701741
[TBL] [Abstract][Full Text] [Related]
9. Effect of circulating immune complexes on the binding of rheumatoid factor to histones.
Gussin HA; Russo KL; Teodorescu M
Ann Rheum Dis; 2000 May; 59(5):351-8. PubMed ID: 10784517
[TBL] [Abstract][Full Text] [Related]
10. [Rheumatoid factors: value of their determination in patients with rheumatoid arthritis].
Ruffatti A; De Silvestro G; Meneghini P; Doria A; Pellizzaro E; Gambari PF; Todesco S
Boll Soc Ital Biol Sper; 1983 Aug; 59(8):1160-4. PubMed ID: 6354211
[TBL] [Abstract][Full Text] [Related]
11. Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis.
Cambridge G; Leandro MJ; Edwards JC; Ehrenstein MR; Salden M; Bodman-Smith M; Webster AD
Arthritis Rheum; 2003 Aug; 48(8):2146-54. PubMed ID: 12905467
[TBL] [Abstract][Full Text] [Related]
12. IgE rheumatoid factor. Occurrence and diagnostic importance in comparison with IgM rheumatoid factor and circulating immune complexes.
Herrmann D; Jäger L; Hein G; Henzgen M; Schlenvoigt G
J Investig Allergol Clin Immunol; 1991 Oct; 1(5):302-7. PubMed ID: 1669588
[TBL] [Abstract][Full Text] [Related]
13. Relationship between the articular manifestations of rheumatoid arthritis and circulating immune complexes detected by three methods and specific classes of rheumatoid factors.
Lessard J; Nunnery E; Cecere F; McDuffy S; Pope RM
J Rheumatol; 1983 Jun; 10(3):411-7. PubMed ID: 6604160
[TBL] [Abstract][Full Text] [Related]
14. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.
Rantapää-Dahlqvist S; de Jong BA; Berglin E; Hallmans G; Wadell G; Stenlund H; Sundin U; van Venrooij WJ
Arthritis Rheum; 2003 Oct; 48(10):2741-9. PubMed ID: 14558078
[TBL] [Abstract][Full Text] [Related]
15. 7S IgG rheumatoid factor and hidden 19S IgM rheumatoid factor in juvenile chronic arthritis.
Roizenblatt S; Goldenberg J; Gabriel A; Hilário MO; Atra E
Allergol Immunopathol (Madr); 1993; 21(5):197-200. PubMed ID: 8160565
[TBL] [Abstract][Full Text] [Related]
16. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
J Mol Recognit; 1999; 12(4):249-57. PubMed ID: 10440996
[TBL] [Abstract][Full Text] [Related]
17. [Dot immunobinding assay for detection of three types of rheumatoid factor and its clinical significance].
Zhou S
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Aug; 15(4):242-4. PubMed ID: 8168202
[TBL] [Abstract][Full Text] [Related]
18. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
J Mol Recognit; 1999; 12(5):249-57. PubMed ID: 10777254
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation endproducts (AGE) on IgG, a target for circulating antibodies in North American Indians with rheumatoid arthritis (RA).
Newkirk MM; LePage K; Niwa T; Rubin L
Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1129-38. PubMed ID: 9846895
[TBL] [Abstract][Full Text] [Related]
20. Blockade of tumour necrosis factor {alpha} significantly alters the serum level of IgG- and IgA-rheumatoid factor in patients with rheumatoid arthritis.
Yazdani-Biuki B; Stadlmaier E; Mulabecirovic A; Brezinschek R; Tilz G; Demel U; Mueller T; Brickmann K; Graninger WB; Brezinschek HP
Ann Rheum Dis; 2005 Aug; 64(8):1224-6. PubMed ID: 16014683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
